Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 2,496,973 $ 12,598,146
Short-term investments 32,358 32,358
Prepaid expenses and other current assets 1,018,969 988,641
Total current assets 3,548,300 13,619,145
Total assets 3,548,300 13,619,145
Current liabilities:    
Accounts payable 1,403,592 7,843,136
Accrued liabilities 1,242,322 1,506,526
Total current liabilities 2,645,914 9,349,662
Share-based compensation liability 716,969 422,002
Warrant liability 108,318 94,185
Total liabilities 3,471,201 9,865,849
Commitments and contingencies
Shareholders' equity (deficit):    
Series 2 Convertible Preferred Shares, no par value, unlimited shares authorized, 1,166,667 shares issued and outstanding as of March 31, 2024 and December 31, 2023
Common shares, no par value, unlimited shares authorized, 18,961,116 and 18,885,254 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively
Additional paid-in capital 97,549,317 97,590,426
Accumulated other comprehensive loss (371,184) (371,184)
Accumulated deficit (97,101,034) (93,465,946)
Total shareholders' equity (deficit) 77,099 3,753,296
Total liabilities and shareholders' equity (deficit) $ 3,548,300 $ 13,619,145